http://www.unboundmedicine.com/medline/ebm/research/didanosineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/20215619/full_citation/Switch_from_protease_inhibitor__to_efavirenz_based_antiretroviral_therapy_improves_quality_of_life_treatment_satisfaction_and_adherence_with_low_rates_of_virological_failure_in_virologically_suppressed_patients_Campo RE, Cohen C, Grimm K, et al. 
Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients. [Journal Article]
Int J STD AIDS 2010 Mar; 21(3):166-71.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20198902/full_citation/[Treatment_of_chronic_hepatitis_C_in_human_immunodeficiency_virus_infected_patients]Begovac J, Romih V 
[Treatment of chronic hepatitis C in human immunodeficiency virus infected patients] [English Abstract, Journal Article]
Acta Med Croatica 2009 Dec; 63(5):423-9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/20190870/full_citation/The_K65R_mutation_in_HIV_1_reverse_transcriptase:_genetic_barriers_resistance_profile_and_clinical_implications_Brenner BG, Coutsinos D 
The K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implications. [JOURNAL ARTICLE]
HIV Ther 2009 Nov 1; 3(6):583-594.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20181971/full_citation/Timing_of_initiation_of_antiretroviral_drugs_during_tuberculosis_therapy_Abdool Karim SS, Naidoo K, Grobler A, et al. 
Timing of initiation of antiretroviral drugs during tuberculosis therapy. [Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.]
N Engl J Med 2010 Feb 25; 362(8):697-706.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/20172412/full_citation/[Cardiovascular_risk_factors_associated_with_antiretroviral_therapy_]Pérez-Camacho I, Camacho A, Torre-Cisneros J, et al. 
[Cardiovascular risk factors associated with antiretroviral therapy.] [JOURNAL ARTICLE]
Enferm Infecc Microbiol Clin 2009 Sep.:24-32.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20167991/full_citation/Mitochondrial_changes_during_D_drug_containing_once_daily_therapy_in_HIV_positive_treatment_naive_patients_Maggiolo F, Roat E, Pinti M, et al. 
Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients. [Journal Article]
Antivir Ther 2010; 15(1):51-9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20164199/full_citation/Relative_contributions_of_baseline_patient_characteristics_and_the_choice_of_statistical_methods_to_the_variability_of_genotypic_resistance_scores:_the_example_of_didanosine_Assoumou L, Houssaïni A, Costagliola D, et al. 
Relative contributions of baseline patient characteristics and the choice of statistical methods to the variability of genotypic resistance scores: the example of didanosine. [JOURNAL ARTICLE]
J Antimicrob Chemother 2010 Feb 17.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/20158454/full_citation/Ubisol_Aqua__:_Coenzyme_Q_10__Prevents_Antiretroviral_Toxic_Neuropathy_in_an_in_vitro_Model_Cherry CL, Mobarok M, Wesselingh SL, et al. 
Ubisol-Aqua(): Coenzyme Q(10) Prevents Antiretroviral Toxic Neuropathy in an in vitro Model. [JOURNAL ARTICLE]
Curr HIV Res 2009 Feb 16.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20158442/full_citation/Risk_Factors_in_Human_Immunodeficiency_Virus/Acquired_Immunodeficiency_Syndrome_Patients_Undergoing_Antiretroviral_Therapy_in_the_State_of_Pernambuco_Brazil:_A_Case_Control_Study_Gelenske T, Bandeira E Farias FA, de Alencar Ximenes RA, et al. 
Risk Factors in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients Undergoing Antiretroviral Therapy in the State of Pernambuco, Brazil: A Case-Control Study. [JOURNAL ARTICLE]
Metab Syndr Relat Disord 2010 Feb 17.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/20158398/full_citation/Efficacy_and_Safety_of_1_Month_Postpartum_Zidovudine_Didanosine_to_Prevent_HIV_Resistance_Mutations_after_Intrapartum_Single_Dose_Nevirapine_Lallemant M, Ngo-Giang-Huong N, Jourdain G, et al. 
Efficacy and Safety of 1-Month Postpartum Zidovudine-Didanosine to Prevent HIV-Resistance Mutations after Intrapartum Single-Dose Nevirapine. [JOURNAL ARTICLE]
Clin Infect Dis 2010 Feb 16.
Abstract | Full Citation